P. T. Duyuler Et Al. , "Homocysteine, visceral adiposity-related novel cardiometabolic risk factors, and exaggerated blood pressure response to the exercise treadmill test," BLOOD PRESSURE MONITORING , vol.22, no.6, pp.333-338, 2017
Duyuler, P. T. Et Al. 2017. Homocysteine, visceral adiposity-related novel cardiometabolic risk factors, and exaggerated blood pressure response to the exercise treadmill test. BLOOD PRESSURE MONITORING , vol.22, no.6 , 333-338.
Duyuler, P. T., Duyuler, S., DEMİR, M., Elalmis, O. U., Guray, U., & Ileri, M., (2017). Homocysteine, visceral adiposity-related novel cardiometabolic risk factors, and exaggerated blood pressure response to the exercise treadmill test. BLOOD PRESSURE MONITORING , vol.22, no.6, 333-338.
Duyuler, Pinar Et Al. "Homocysteine, visceral adiposity-related novel cardiometabolic risk factors, and exaggerated blood pressure response to the exercise treadmill test," BLOOD PRESSURE MONITORING , vol.22, no.6, 333-338, 2017
Duyuler, Pinar T. Et Al. "Homocysteine, visceral adiposity-related novel cardiometabolic risk factors, and exaggerated blood pressure response to the exercise treadmill test." BLOOD PRESSURE MONITORING , vol.22, no.6, pp.333-338, 2017
Duyuler, P. T. Et Al. (2017) . "Homocysteine, visceral adiposity-related novel cardiometabolic risk factors, and exaggerated blood pressure response to the exercise treadmill test." BLOOD PRESSURE MONITORING , vol.22, no.6, pp.333-338.
@article{article, author={Pinar Turker Duyuler Et Al. }, title={Homocysteine, visceral adiposity-related novel cardiometabolic risk factors, and exaggerated blood pressure response to the exercise treadmill test}, journal={BLOOD PRESSURE MONITORING}, year=2017, pages={333-338} }